Professor Kevin... - The Institute of Cancer Research | Facebook
Kevin Harrington (@kevhar6763) / Twitter
Skin cancer: below the surface | The Royal Marsden
SAB and I-O AB - T3 Pharma
Immunotherapy: changing the face of melanoma treatment | TRM CancerBRC
PATRIOT: ATR inhibitor monotherapy in advanced solid tumors | VJOncology
Potential of immunotherapy in head and neck cancer | VJOncology
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
RM Magazine - Winter 2022 by The Royal Marsden - Issuu
Scientific Advisory Board | Nanobiotix
Dr. Harrington on the KEYNOTE-048 Trial in Recurrent/Metastatic Head and Neck Cancer
Cancer: Scientists aim to double survival within a decade | The Independent
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Professor Kevin Harrington | The Royal Marsden
Potential of immunotherapy in head and neck cancer | VJOncology
My final lifeline" | The Biomedical Scientist Magazine of the IBMS
Professor Kevin Harrington - The Institute of Cancer Research, London
World-first centre for recurrent head & neck cancer - Professor Christopher Nutting Oncology
The value of PD-L1 as a biomarker beyond lung cancers - YouTube
Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
Kevin Harrington, PhD on Importance of KEYNOTE-048 #ASCO2020 #ASCO
